VVOS — Vivos Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.80m
- $11.13m
- $17.44m
Brief: Vivos Therapeutics Receives FDA Clearance Of Its DNA Oral Appliance For Treatment Of Obstructive Sleep Apnea
Brief: Vivos Therapeutics Posts Qtrly Loss Of $0.26 Per Share
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Vivos Therapeutics Announces New Revenue Stream Through Medical Billing Relationship With Nexus Dental Systems
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Vivos Therapeutics Receives Notice From Nasdaq Regarding Late Filing Of Third Quarter 2022 Quarterly Report On Form 10-Q
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Vivos Therapeutics Provides Update On Revenue Recognition Review
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Vivos Therapeutics Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Vivos Therapeutics Provides Update On Second Quarter Earnings Delay
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Vivos Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Vivos Therapeutics Announces Multiple Regulatory Clearances In Australia For Its Entire Line Of Oral Appliances
Brief: Vivos Therapeutics Announces Exclusive Distribution Agreement With GM Instruments For U.S., Canada
Vivos Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview